Strategic Developments in the US Infection Control Market

15/07/2026 2 min read

Views

The US Infection Control Market growth continues to expand as long-term care and ambulatory settings emerge as critical venues for infection prevention. With nursing homes, assisted living facilities, and dialysis centers experiencing high rates of multidrug-resistant organism transmission, regulatory attention is intensifying. The rising acuity of patients in outpatient settings, including infusion centers and ambulatory surgery facilities, is extending infection control responsibilities beyond traditional hospitals. Additionally, the shift toward home-based care is creating new challenges for maintaining sterile technique in non-traditional environments.

To understand deeper trends, refer to US Infection Control Market, which highlights how CMS requirements for infection prevention and control programs in nursing homes are driving dedicated staffing and training investments. The development of portable disinfection devices and telehealth-supported oversight is further influencing market dynamics, enabling infection control in distributed care models. Standardized infection ratios for outpatient settings are also being developed for benchmarking.

Furthermore, the market is witnessing increased collaborations between acute care hospitals and post-acute care partners. These partnerships are aimed at preventing readmissions through coordinated transition of care, shared surveillance data, and unified antibiotic stewardship. As healthcare delivery becomes increasingly fragmented across settings, continuity of infection prevention and inter-facility communication are becoming essential factors influencing population-level HAI reduction and patient safety.